ABBV

$0.00

(

+0.00%

)
Quote details

stock

AbbVie Inc

NYSE | ABBV

210.42

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 9, 2025)

$371.72B

Market Cap

100.2

P/E Ratio

2.1

EPS

$214.80

52 Week High

$159.41

52 Week Low

HEALTHCARE

Sector

ABBV Chart

Recent Chart
Price Action

ABBV Technicals

Tags:

ABBV Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $39B
Total Revenue $56B
Cost Of Revenue $17B
Costof Goods And Services Sold $17B
Operating Income $9.1B
Selling General And Administrative $11B
Research And Development $13B
Operating Expenses $30B
Investment Income Net -
Net Interest Income -$2.2B
Interest Income $648M
Interest Expense $2.8B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.4B
Income Before Tax $3.7B
Income Tax Expense -$570M
Interest And Debt Expense -
Net Income From Continuing Operations $4.3B
Comprehensive Income Net Of Tax -
Ebit $6.5B
Ebitda $15B
Net Income $4.3B

Revenue & Profitability

Earnings Performance

ABBV Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $135B
Total Current Assets $26B
Cash And Cash Equivalents At Carrying Value $5.5B
Cash And Short Term Investments $5.5B
Inventory $4.2B
Current Net Receivables $11B
Total Non Current Assets $110B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $60B
Intangible Assets Excluding Goodwill $60B
Goodwill $35B
Investments -
Long Term Investments $279M
Short Term Investments $31M
Other Current Assets $4.9B
Other Non Current Assets -
Total Liabilities $132B
Total Current Liabilities $39B
Current Accounts Payable $2.9B
Deferred Revenue -
Current Debt -
Short Term Debt $6.8B
Total Non Current Liabilities $93B
Capital Lease Obligations -
Long Term Debt $60B
Current Long Term Debt $6.8B
Long Term Debt Noncurrent -
Short Long Term Debt Total $68B
Other Current Liabilities $29B
Other Non Current Liabilities $28B
Total Shareholder Equity $3.3B
Treasury Stock -
Retained Earnings -$7.9B
Common Stock $18M
Common Stock Shares Outstanding $1.8B

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $19B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.4B
Capital Expenditures $974M
Change In Receivables -
Change In Inventory -$319M
Profit Loss -
Cashflow From Investment -$21B
Cashflow From Financing -$5.2B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $11B
Dividend Payout Common Stock $11B
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1.7B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $4.3B

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $39B
Total Revenue $56B
Cost Of Revenue $17B
Costof Goods And Services Sold $17B
Operating Income $9.1B
Selling General And Administrative $11B
Research And Development $13B
Operating Expenses $30B
Investment Income Net -
Net Interest Income -$2.2B
Interest Income $648M
Interest Expense $2.8B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.4B
Income Before Tax $3.7B
Income Tax Expense -$570M
Interest And Debt Expense -
Net Income From Continuing Operations $4.3B
Comprehensive Income Net Of Tax -
Ebit $6.5B
Ebitda $15B
Net Income $4.3B

Dividends

Field Value
Ex Dividend Date 2025-10-15
Declaration Date 2025-09-05
Record Date 2025-10-15
Payment Date 2025-11-14
Amount 1.64

ABBV News

ABBV Profile

AbbVie Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

JEM
+130.50%
$0.68
CGBS
-39.47%
$0.03
MMA
+70.58%
$1.45
NVDA
+1.45%
$170.76
ITP
+38.72%
$0.28
CWD
+323.72%
$9.11
ISPC
+159.67%
$1.94
BITF
+24.21%
$1.59
EZGO
-1.00%
$0.13
ONDS
-10.06%
$5.45
SNAP
+0.83%
$7.28
YOUL
+24.43%
$2.19
NBIS
+49.42%
$95.72
VHAI
0.00%
$0.00
MARA
+4.80%
$15.93
TPIC
-45.91%
$0.12
WULF
+11.95%
$10.30
STEC
+359.09%
$3.03
CIFR
+19.43%
$9.22
SOUN
-2.87%
$14.85
DSY
+169.60%
$2.75
AXDX
-61.36%
$0.03
RIOT
+13.16%
$15.21
AAPL
-1.48%
$234.35
ABEV
+0.90%
$2.22
AAL
-1.46%
$12.76
CDTG
+88.43%
$1.04
NXTT
-1.78%
$0.14
PLTR
+4.01%
$162.36
DNN
+0.42%
$2.39
BON
+24.67%
$1.92
IMG
+11.94%
$0.24
RAYA
-8.36%
$0.03
NIO
+1.78%
$6.28
LYT
-16.77%
$0.09
LGHL
+32.66%
$1.99
TSLA
+0.16%
$346.97
QS
-10.11%
$8.52
HOOD
+1.04%
$118.50
IREN
+15.27%
$30.19
SOFI
+0.03%
$25.97
UNH
+8.64%
$347.92
RGTI
+8.91%
$16.50
WBD
-0.72%
$12.26
TLRY
+1.78%
$1.13
GRAB
+1.92%
$5.29
AMD
+2.91%
$155.82
IXHL
-6.27%
$0.54
INTC
-0.16%
$24.44
TECK
+11.27%
$39.07
F
-1.71%
$11.49
ORCL
+1.27%
$241.51
NCLH
+3.42%
$25.37
CRWV
+7.12%
$100.22
BAC
+1.67%
$50.29
RMBL
+60.50%
$3.21
KVUE
+2.38%
$18.87
BTBT
+8.62%
$2.77
ADD
-25.47%
$0.05
GOOGL
+2.38%
$239.63
SMCI
+7.19%
$42.92
HL
+0.59%
$10.18
T
+1.79%
$29.42
SRM
+53.27%
$10.30
QBTS
+4.73%
$16.14
BTG
-1.39%
$4.23
AUR
-1.04%
$5.70
KEY
-0.26%
$19.10
BABA
+4.17%
$147.10
PFE
+0.65%
$24.71
BBD
-0.63%
$3.13
PCG
+2.81%
$14.97
APLD
+9.27%
$15.20
RIVN
-0.35%
$13.94
BINI
-19.30%
$0.12
MULN
-19.30%
$0.12
XHG
+39.95%
$1.31
PLUG
-2.08%
$1.41
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RZLV
+21.64%
$5.62
AGNC
+0.09%
$10.35
WLGS
-5.57%
$0.04
YAAS
-10.39%
$0.07
JD
+3.10%
$33.86
BMNR
+1.84%
$44.60
AMZN
+1.01%
$238.24
AVGO
-2.59%
$336.67
ADAP
+15.76%
$0.04
PTNM
+65.32%
$4.53
ETWO
0.00%
$3.30
LGCL
+6.88%
$0.52
NFE
0.00%
$1.40
VALE
-0.95%
$10.35
CASK
+20.55%
$0.48
FCX
-5.93%
$43.89
HBAN
-0.50%
$17.64
UUUU
+9.91%
$13.08
WLDS
-0.97%
$1.02
SBET
+6.50%
$16.69
JEM
+130.50%
$0.68
CGBS
-39.47%
$0.03
MMA
+70.58%
$1.45
NVDA
+1.45%
$170.76
ITP
+38.72%
$0.28
CWD
+323.72%
$9.11
ISPC
+159.67%
$1.94
BITF
+24.21%
$1.59
EZGO
-1.00%
$0.13
ONDS
-10.06%
$5.45
SNAP
+0.83%
$7.28
YOUL
+24.43%
$2.19
NBIS
+49.42%
$95.72
VHAI
0.00%
$0.00
MARA
+4.80%
$15.93
TPIC
-45.91%
$0.12
WULF
+11.95%
$10.30
STEC
+359.09%
$3.03
CIFR
+19.43%
$9.22
SOUN
-2.87%
$14.85
DSY
+169.60%
$2.75
AXDX
-61.36%
$0.03
RIOT
+13.16%
$15.21
AAPL
-1.48%
$234.35
ABEV
+0.90%
$2.22
AAL
-1.46%
$12.76
CDTG
+88.43%
$1.04
NXTT
-1.78%
$0.14
PLTR
+4.01%
$162.36
DNN
+0.42%
$2.39
BON
+24.67%
$1.92
IMG
+11.94%
$0.24
RAYA
-8.36%
$0.03
NIO
+1.78%
$6.28
LYT
-16.77%
$0.09
LGHL
+32.66%
$1.99
TSLA
+0.16%
$346.97
QS
-10.11%
$8.52
HOOD
+1.04%
$118.50
IREN
+15.27%
$30.19
SOFI
+0.03%
$25.97
UNH
+8.64%
$347.92
RGTI
+8.91%
$16.50
WBD
-0.72%
$12.26
TLRY
+1.78%
$1.13
GRAB
+1.92%
$5.29
AMD
+2.91%
$155.82
IXHL
-6.27%
$0.54
INTC
-0.16%
$24.44
TECK
+11.27%
$39.07
F
-1.71%
$11.49
ORCL
+1.27%
$241.51
NCLH
+3.42%
$25.37
CRWV
+7.12%
$100.22
BAC
+1.67%
$50.29
RMBL
+60.50%
$3.21
KVUE
+2.38%
$18.87
BTBT
+8.62%
$2.77
ADD
-25.47%
$0.05
GOOGL
+2.38%
$239.63
SMCI
+7.19%
$42.92
HL
+0.59%
$10.18
T
+1.79%
$29.42
SRM
+53.27%
$10.30
QBTS
+4.73%
$16.14
BTG
-1.39%
$4.23
AUR
-1.04%
$5.70
KEY
-0.26%
$19.10
BABA
+4.17%
$147.10
PFE
+0.65%
$24.71
BBD
-0.63%
$3.13
PCG
+2.81%
$14.97
APLD
+9.27%
$15.20
RIVN
-0.35%
$13.94
BINI
-19.30%
$0.12
MULN
-19.30%
$0.12
XHG
+39.95%
$1.31
PLUG
-2.08%
$1.41
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RZLV
+21.64%
$5.62
AGNC
+0.09%
$10.35
WLGS
-5.57%
$0.04
YAAS
-10.39%
$0.07
JD
+3.10%
$33.86
BMNR
+1.84%
$44.60
AMZN
+1.01%
$238.24
AVGO
-2.59%
$336.67
ADAP
+15.76%
$0.04
PTNM
+65.32%
$4.53
ETWO
0.00%
$3.30
LGCL
+6.88%
$0.52
NFE
0.00%
$1.40
VALE
-0.95%
$10.35
CASK
+20.55%
$0.48
FCX
-5.93%
$43.89
HBAN
-0.50%
$17.64
UUUU
+9.91%
$13.08
WLDS
-0.97%
$1.02
SBET
+6.50%
$16.69

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.